Learn More
Invitrogen™ Human LZIP (aa 182-225) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (93%), Rat (93%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65086 (PA5-65086. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Specifications
Specifications
| Accession Number | O43889 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10488 |
| Name | Human LZIP (aa 182-225) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AU044960; AW538053; basic leucine zipper protein; C80076; cAMP responsive element binding protein 3; cAMP-responsive element-binding protein 3; CREB3; CREB-3; cyclic AMP response element (CRE)-binding protein/activating transcription factor 1; cyclic AMP-responsive element-binding protein 3; leucin zipper proitein; Leucine zipper protein; Luman; LZIP; LZIP-1; LZIP-2; N-terminal Luman; Processed cyclic AMP-responsive element-binding protein 3; sLZIP; small leucine zipper protein; transcription factor LZIP; transcription factor LZIP-alpha |
| Common Name | LZIP |
| Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.